Project Details
Projekt Print View

Mechanisms of Integrin α2β1 driven cell-matrix interaction in the course of bone regeneration and fracture healing

Subject Area Orthopaedics, Traumatology, Reconstructive Surgery
Term from 2020 to 2023
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 437825722
 
Final Report Year 2024

Final Report Abstract

The project aimed to characterize the role of integrin α2β1 and its influence on cell-matrix interactions and matrix formation during fracture healing. It investigated the mechanism behind the increased collagen formation and deposition, as well as the expression of pro-osteoblastic genes when integrin-α2 expression is suppressed. Finally, the potential of inhibiting integrin α2 to improve fracture healing was explored. Characterization of the Role of Integrin α2: Studies on mice at different stages of fracture healing (7, 14, and 21 days) showed that integrin-α2-deficient animals exhibited earlier mineralization of the fracture callus. Histological analyses also revealed that both the formation and degradation of the cartilaginous callus occurred earlier in integrin-α2-deficient animals, indicating accelerated fracture healing. Mechanism of Collagen Formation and Gene Expression: It was demonstrated that the early activation of the BMP (Bone Morphogenetic Protein) signaling pathway in integrin-α2- deficient animals leads to increased extracellular matrix formation and osteoblast differentiation. These findings were reproduced in cell culture experiments. Primary osteoblasts from integrin-α2-deficient animals exhibited enhanced mineralization competence, mediated by a secreted factor identified as BMP-2, similar to that observed during fracture healing. Potential of Integrin α2 Inhibition: Attempts to inhibit integrin α2β1 using the specific snake venom rhodocetin were unsuccessful. MC3T3 cells were found to be unsuitable due to low integrin α2 expression and lack of significant BMP-2 activation. Alternatives, such as the integrin-α2-blocking antibody AB1950Z, resulted in off-target effects. The investigation of different carrier substances (agarose, collagen, Matrigel, blood coagulate) for drug delivery showed that none achieved sufficiently delayed release kinetics. A planned osteotomy could not be carried out due to organizational and personnel constraints. Results and Discussion: The project confirmed the hypothesis that integrin-α2 deficiency promotes fracture healing. Further research is required to fully understand the mechanistic relationship, which could be achieved through unbiased analytical approaches such as proteomics or single-cell sequencing. siRNA technology for the inhibition of integrin α2 showed promising results and will be pursued as a potential therapeutic approach. A clinical study on the role of integrin α2 in human fracture healing has begun, aiming to determine whether integrin α2 can serve as a prognostic marker for poor fracture healing.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung